中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
24期
85-86
,共2页
等离子前列腺电切术%绿激光前列腺汽化术%良性前列腺增生症
等離子前列腺電切術%綠激光前列腺汽化術%良性前列腺增生癥
등리자전렬선전절술%록격광전렬선기화술%량성전렬선증생증
Transurethral plasmaknetic resection of prostate%Phosphate laser vaporization prostatectomy%Benign prostatic hyper-plasia
目的:探讨研究经尿道等离子电切术和绿激光汽化电切术治疗良性前列腺增生症的有效性和安全性。方法随机选取从2012年2月-2015年4月于该院诊治的120例良性前列腺增生老年患者,按照采取手术方式不同,分为PVP组(60例)与TUPKRP组(60例),记录两组患者的手术时间和术中出血量,以及患者术后的冲洗时间等内容,同时记录两组患者导尿管留置时间,术后3个月两组患者的QOL、IPSS和Qmax等指标。结果两组患者治疗后,在导尿留置时间和术中出血量,术后膀胱痉挛发生率和手术并发症发生率等方面比较均差异有统计学意义(P<0.05)。两组拔管后的24 hQmax、术后术后3个月Qmax、3个月IPSS评分、术后3个月QOL评分数值均差异无统计学意义(P>0.05)。结论PVP与TUPKRP在总体上治疗效果相同,但是在术中出血和术后拔管等方面,PVP法--优于TUPKRP。
目的:探討研究經尿道等離子電切術和綠激光汽化電切術治療良性前列腺增生癥的有效性和安全性。方法隨機選取從2012年2月-2015年4月于該院診治的120例良性前列腺增生老年患者,按照採取手術方式不同,分為PVP組(60例)與TUPKRP組(60例),記錄兩組患者的手術時間和術中齣血量,以及患者術後的遲洗時間等內容,同時記錄兩組患者導尿管留置時間,術後3箇月兩組患者的QOL、IPSS和Qmax等指標。結果兩組患者治療後,在導尿留置時間和術中齣血量,術後膀胱痙攣髮生率和手術併髮癥髮生率等方麵比較均差異有統計學意義(P<0.05)。兩組拔管後的24 hQmax、術後術後3箇月Qmax、3箇月IPSS評分、術後3箇月QOL評分數值均差異無統計學意義(P>0.05)。結論PVP與TUPKRP在總體上治療效果相同,但是在術中齣血和術後拔管等方麵,PVP法--優于TUPKRP。
목적:탐토연구경뇨도등리자전절술화록격광기화전절술치료량성전렬선증생증적유효성화안전성。방법수궤선취종2012년2월-2015년4월우해원진치적120례량성전렬선증생노년환자,안조채취수술방식불동,분위PVP조(60례)여TUPKRP조(60례),기록량조환자적수술시간화술중출혈량,이급환자술후적충세시간등내용,동시기록량조환자도뇨관류치시간,술후3개월량조환자적QOL、IPSS화Qmax등지표。결과량조환자치료후,재도뇨류치시간화술중출혈량,술후방광경련발생솔화수술병발증발생솔등방면비교균차이유통계학의의(P<0.05)。량조발관후적24 hQmax、술후술후3개월Qmax、3개월IPSS평분、술후3개월QOL평분수치균차이무통계학의의(P>0.05)。결론PVP여TUPKRP재총체상치료효과상동,단시재술중출혈화술후발관등방면,PVP법--우우TUPKRP。
Objective To explore the effectiveness and safety of transurethral plasmaknetic resection of prostate (TUPKRP) and phosphate laser vaporization prostatectomy (PVP) in treating benign prostatic hyperplasia. Methods From February 2012 to April 2015, 120 patients with benign prostatic hyperplasia were selected,based on which we divided them into PVP group (n=60) and TUPKRP group (n=60) to record the operative duration, intraoperative blood loss, postoperative bladder perfusion time and bladder catheterization duration, as well as indicators including QOL, IPSS, Qmax 3 months after operation. Results There were statistically significant differences in bladder catheterization duration, intraoperative blood loss, postoperative bladder spasm rate and compli-cation but were not in Qmax 24h after extubation, Qmax, IPSS score and IPSS score 3 months after operation, between the two groups, P<0.05 and P>0.05 respectively. Conclusion Although the overall effectiveness of PVP is similar to that of TUPKRP, PVP is superior to TUPKRP in bladder catheterization duration, intraoperative blood loss etc.